Yield10 Bioscience Inc
General ticker "YTEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $211.7K
Yield10 Bioscience Inc does not follow the US Stock Market performance with the rate: -40.3%.
Estimated limits based on current volatility of 162.8%: low -0.01$, high 0.05$
Factors to consider:
- US accounted for 100.0% of revenue in the fiscal year ended 2022-12-31
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.93$, 20.97$]
- 2024-12-30 to 2025-12-30 estimated range: [4.39$, 13.05$]
Financial Metrics affecting the YTEN estimates:
- Negative: Non-GAAP EPS, $ of -43.68 <= 0.10
- Negative: Operating profit margin, % of -99.59 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -84.58 <= 2.35
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term YTEN quotes
Long-term YTEN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.61MM | $0.45MM | $0.06MM |
| Operating Expenses | $12.31MM | $13.90MM | $14.48MM |
| Operating Income | $-11.69MM | $-13.45MM | $-14.42MM |
| Non-Operating Income | $0.70MM | $0.04MM | $-0.04MM |
| R&D Expense | $6.20MM | $7.75MM | $8.32MM |
| Income(Loss) | $-10.99MM | $-13.41MM | $-14.46MM |
| Taxes | $0.04MM | $0.16MM | $0.00MM |
| Profit(Loss)* | $-11.03MM | $-13.57MM | $-14.46MM |
| Stockholders Equity | $16.03MM | $4.40MM | $-2.48MM |
| Assets | $20.41MM | $8.09MM | $3.91MM |
| Operating Cash Flow | $-9.25MM | $-11.40MM | $-10.07MM |
| Capital expenditure | $0.19MM | $0.15MM | $0.05MM |
| Investing Cash Flow | $-4.58MM | $8.52MM | $1.95MM |
| Financing Cash Flow | $15.75MM | $-0.04MM | $6.87MM |
| Earnings Per Share** | $-55.95 | $-66.25 | $-43.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.